Ortiz-Fernández Lourdes, García-Lozano José-Raúl, Montes-Cano Marco-Antonio, Conde-Jaldón Marta, Ortego-Centeno Norberto, García-Hernández Francisco-José, Espinosa Gerard, Graña-Gil Genaro, Sánchez-Bursón Juan, Blanco Ricardo, Barnosi-Marín Ana-Celia, Solans Roser, Fanlo Patricia, Rodríguez-Carballeira Mónica, Camps Teresa, Castañeda Santos, Núñez-Roldán Antonio, Martín Javier, González-Escribano María-Francisca
From the Servicio de Inmunología, IBiS, Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Sevilla, Sevilla; Servicio de Medicina Interna, Hospital Clínico San Cecilio, Granada; Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Sevilla; Servicio de Enfermedades Autoinmunes, Hospital Clinic, Barcelona; Servicio de Reumatología, Complejo Hospitalario Universitario, La Coruña; Servicio de Reumatología, Hospital Universitario de Valme, Sevilla; Servicio de Reumatología, Hospital Marqués de Valdecilla, Santander; Servicio de Medicina Interna, Hospital de Torrecárdenas, Almería; Servicio de Medicina Interna, Hospital Vall d'Hebron, Barcelona; Servicio de Medicina Interna, Hospital Virgen del Camino, Pamplona; Servicio de Medicina Interna, Hospital Universitari Mútua, Terrassa; Servicio de Medicina Interna, Hospital Universitario Carlos Haya, Málaga; Servicio de Reumatología, Hospital de la Princesa, Madrid; Instituto de Parasitología y Biomedicina López Neyra, CSIC, Granada, Spain.L. Ortíz-Fernández, BSc; J.R. García-Lozano, MD, PhD; M.A. Montes-Cano, PhD; M. Conde-Jaldón, BSc; A. Núñez-Roldán, MD, PhD; M.F. González-Escribano, PhD; Servicio de Inmunología, Hospital Universitario Virgen del Rocío; N. Ortego-Centeno, MD, Servicio de Medicina Interna, Hospital Clínico San Cecilio; F.J. García-Hernández, MD, Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío; G. Espinosa, MD, Servicio de Enfermedades Autoinmunes, Hospital Clinic; G. Graña-Gil, MD, Servicio de Reumatología, Complejo Hospitalario Universitario; J. Sánchez-Bursón, MD, Servicio de Reumatología, Hospital Universitario de Valme; R. Blanco, MD, Servicio de Reumatología, Hospital Marqués de Valdecilla; A-C. Barnosi-Marín, MD, Servicio de Medicina Interna, Hospital de Torrecárdenas; R. Solans, MD, Servicio de Medicina Interna, Hospital Vall d'Hebron; P. Fanlo, MD, Servicio de Medi
J Rheumatol. 2015 Apr;42(4):695-701. doi: 10.3899/jrheum.140949. Epub 2015 Feb 1.
Behçet disease (BD) is a multifactorial disease in which infectious agents have been proposed as triggers in genetically predisposed individuals. The aim of our study was to investigate the role of innate immunity receptors, specifically the nucleic acid sensors, in susceptibility to BD.
Seventy-four tag single nucleotide polymorphisms (tSNP) selected in 9 candidate genes (DDX58, IFIH1, TLR3, TLR7, TLR8, AIM2, IFI16, ZBP1, and TLR9) were genotyped in 371 patients and 854 controls. Assays of mRNA expression and allele-specific transcript quantification (ASTQ) were performed in 110 and 50 controls, respectively.
Patients and controls were genotyped and 2 tSNP (rs6940 in IFI16 and rs855873 in AIM2) were associated with BD. To confirm this association, these tSNP were genotyped in 850 additional controls, and the total cohort was randomly divided into 2 cohorts. The association of these 2 tSNP with the disease remained in both cohorts. One haplotype (rs6940T-rs855873G) was identified as a risk factor (OR 1.41, 95% CI 1.06-1.86, p = 0.015), and another (rs6940A-rs855873A) as a protective factor (OR 0.65, 95% CI 0.47-0.90, p = 0.009). Samples with the risk haplotype had lower IFI16 expression levels than samples with the protective (0.99 ± 0.29 vs 1.23 ± 0.50, p = 0.022). Consistently, in the ASTQ assays performed with the nonsynonymous rs6940 SNP, the risk allele had lower IFI16 expression levels than the protective (p = 0.027).
Our findings suggest association of IFI16, a cytosolic sensor of dsDNA and mediator of the AIM2 inflammasome-dependent pathway, in susceptibility to BD. Differences genetically determined in the levels of this molecule could be the cause of this association.
白塞病(BD)是一种多因素疾病,在遗传易感性个体中,感染因子被认为是触发因素。我们研究的目的是调查天然免疫受体,特别是核酸传感器,在BD易感性中的作用。
对9个候选基因(DDX58、IFI16、TLR3、TLR7、TLR8、AIM2、IFI16、ZBP1和TLR9)中选择的74个标签单核苷酸多态性(tSNP)在371例患者和854例对照中进行基因分型。分别在110例和50例对照中进行mRNA表达测定和等位基因特异性转录本定量(ASTQ)。
对患者和对照进行基因分型,发现2个tSNP(IFI16中的rs6940和AIM2中的rs855873)与BD相关。为了证实这种关联,在另外850例对照中对这些tSNP进行基因分型,并将整个队列随机分为2个队列。这2个tSNP与疾病的关联在两个队列中均存在。一种单倍型(rs6940T-rs855873G)被确定为危险因素(OR 1.41,95%CI 1.06-1.86,p = 0.015),另一种(rs6940A-rs855873A)为保护因素(OR 0.65,95%CI 0.47-0.90,p = 0.009)。具有危险单倍型的样本IFI16表达水平低于具有保护单倍型的样本(0.99±0.29对1.23±0.50,p = 0.022)。同样,在对非同义rs6940 SNP进行的ASTQ测定中,危险等位基因的IFI16表达水平低于保护等位基因(p = 0.027)。
我们的研究结果表明,双链DNA的胞质传感器IFI16与AIM2炎性小体依赖性途径的介质与BD易感性相关。该分子水平上的遗传决定差异可能是这种关联的原因。